These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36570391)

  • 1. Exploring the provider and organization level barriers to medication for opioid use disorder treatment for Black Americans: A study protocol.
    Gilbert LR; Starks S; Gray J; Reitzel LR; Obasi EM
    Public Health Pract (Oxf); 2022 Dec; 4():100308. PubMed ID: 36570391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.
    Taylor EN; Timko C; Binswanger IA; Harris AHS; Stimmel M; Smelson D; Finlay AK
    Subst Abus; 2022; 43(1):556-563. PubMed ID: 34586978
    [No Abstract]   [Full Text] [Related]  

  • 4. Contextualizing medications for opioid use disorder and peer support service provision in the probation system with implementation science.
    Kang AW; Bailey A; Napoleon S; Martin R
    BMC Public Health; 2024 Mar; 24(1):658. PubMed ID: 38429688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contextualizing Medications for Opioid Use Disorder and Peer Support Service Provision in the Probation System with Implementation Science.
    Kang A; Bailey A; Napoleon S; Martin R
    Res Sq; 2023 Nov; ():. PubMed ID: 38045366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol.
    Martin RA; Stein LAR; Rohsenow DJ; Belenko S; Hurley LE; Clarke JG; Brinkley-Rubinstein L
    J Subst Abuse Treat; 2021 Sep; 128():108364. PubMed ID: 33741216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study.
    Poulsen MN; Asdell PB; Berrettini W; McBryan K; Rahm AK
    SSM Ment Health; 2022 Dec; 2():. PubMed ID: 36776723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder.
    Robles M; Mortazavi L; Vannerson J; Matthias MS
    Teach Learn Med; 2022; 34(5):514-521. PubMed ID: 33974460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.
    Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM
    Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities.
    Hagedorn HJ; Gustavson AM; Ackland PE; Bangerter A; Bounthavong M; Clothier B; Harris AHS; Kenny ME; Noorbaloochi S; Salameh HA; Gordon AJ
    J Gen Intern Med; 2022 Nov; 37(14):3594-3602. PubMed ID: 34981352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.
    Scott CK; Grella CE; Dennis ML; Carnevale J; LaVallee R
    Health Justice; 2022 Dec; 10(1):36. PubMed ID: 36538121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.
    King Z; Kramer C; Latkin C; Sufrin C
    J Subst Abuse Treat; 2021 Jul; 126():108338. PubMed ID: 34116823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.
    Gustavson AM; Kenny ME; Wisdom JP; Salameh HA; Ackland PE; Gordon AJ; Hagedorn HJ
    Addict Sci Clin Pract; 2021 Aug; 16(1):51. PubMed ID: 34362445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Patient Engagement in Treatment for Opioid Use Disorder: Primary Care Team Perspectives on Influencing Factors.
    Austin EJ; Chen J; Soyer E; Idrisov B; Briggs ES; Ferro L; Saxon AJ; Fortney JC; Curran GM; Moghimi Y; Blanchard BE; Williams EC; Ratzliff AD; Ruiz MS; Koch U
    J Gen Intern Med; 2024 Jul; ():. PubMed ID: 39073482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
    Nunes EV; Levin FR; Reilly MP; El-Bassel N
    J Subst Abuse Treat; 2021 Mar; 122():108196. PubMed ID: 33221125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder.
    Dowd WN; Barch DH; Seibert JH; Mark TL
    J Subst Abuse Treat; 2022 Sep; 140():108824. PubMed ID: 35780730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.
    Parlier-Ahmad AB; Pugh M; Martin CE
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1557-1567. PubMed ID: 34254271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.